Your request to link to rcsb for VIM-1

• 1KO2: vim-2, a zn-beta-lactamase from pseudomonas aeruginosa with an oxidized cys (cysteinesulfonic) (10.1016/J.JMB.2007.11.012 )
• 1KO3: vim-2, a zn-beta-lactamase from pseudomonas aeruginosa with cys221 reduced (10.1016/J.JMB.2007.11.012 )
• 2WHG: crystal structure of the di-zinc metallo-beta-lactamase vim- 4 from pseudomonas aeruginosa (10.1128/AAC.01486-09 )
• 2WRS: crystal structure of the mono-zinc metallo-beta-lactamase vim-4 from pseudomonas aeruginosa (10.1021/JM100213C )
• 2YZ3: crystallographic investigation of inhibition mode of the vim-2 metallo-beta-lactamase from pseudomonas aeruginosa with mercaptocarboxylate inhibitor (10.1021/JM701031N )
• 4BZ3: crystal structure of the metallo-beta-lactamase vim-2 (10.1128/AAC.01335-15 )
• 4C1D: crystal structure of the metallo-beta-lactamase vim-2 with l-captopril (10.1128/AAC.01335-15 )
• 4C1E: crystal structure of the metallo-beta-lactamase vim-2 with d-captopril (10.1128/AAC.01335-15 )
• 4FR7: crystal structure of the metallo-beta-lactamase vim-31 in its reduced form at 1.61 a (10.1111/FEBS.13283 )
• 4FSB: crystal structure of the metallo-beta-lactamase vim-31 in its oxidized form at 1.88 a (10.1111/FEBS.13283 )
• 4NQ2: structure of zn(ii)-bound metallo-beta-lactamse vim-2 from pseudomonas aeruginosa (10.1021/BI500916Y )
• 4PVO: crystal structure of vim-2 metallo-beta-lactamase in complex with ml302 and ml302f (10.1038/NCHEM.2110 )
• 4PVT: crystal structure of vim-2 metallo-beta-lactamase in complex with ml302f (10.1038/NCHEM.2110 )
• 4UA4: structure of the vim-2 metallo-beta-lactamase in complex with a bisthiazolidine inhibitor
• 4UWO: native di-zinc vim-26. leu224 in vim-26 from klebsiella pneumoniae has implications for drug binding. (10.1111/FEBS.13200 )
• 4UWP: penta zn1 coordination. leu224 in vim-26 from klebsiella pneumoniae has implications for drug binding. (10.1111/FEBS.13200 )
• 4UWR: mono-zinc vim-26. leu224 in vim-26 from klebsiella pneumoniae has implications for drug binding. (10.1111/FEBS.13200 )
• 4UWS: vim-26-peg. leu224 in vim-26 from klebsiella pneumoniae has implications for drug binding. (10.1111/FEBS.13200 )
• 5A87: crystal structure of the metallo-beta-lactamase vim-5 (10.1128/AAC.01768-15 )
• 5ACU: vim-2-nat, discovery of novel inhibitor scaffolds against the metallo-beta-lactamase vim-2 by spr based fragment screening (10.1021/ACS.JMEDCHEM.5B01289 )
• 5ACV: vim-2-ox, discovery of novel inhibitor scaffolds against the metallo- beta-lactamase vim-2 by spr based fragment screening (10.1021/ACS.JMEDCHEM.5B01289 )
• 5ACW: vim-2-1, discovery of novel inhibitor scaffolds against the metallo- beta-lactamase vim-2 by spr based fragment screening (10.1021/ACS.JMEDCHEM.5B01289 )
• 5ACX: vim-2-2, discovery of novel inhibitor scaffolds against the metallo- beta-lactamase vim-2 by spr based fragment screening (10.1021/ACS.JMEDCHEM.5B01289 )
• 5FQC: crystal structure of the metallo-beta-lactamase vim-2 with 2c (10.1038/NCOMMS12406 )
• 5K48: vim-2 metallo beta lactamase in complex with 3-(mercaptomethyl)-[1,1'- biphenyl]-4-carboxylic acid (10.1021/ACS.JMEDCHEM.7B01728 )
• 5LCA: vim-2 metallo-beta-lactamase in complex with 3-oxo-2-(3- (trifluoromethyl)phenyl)isoindoline-4-carboxylic acid (compound 17) (10.1039/C6SC04524C )
• 5LCF: vim-2 metallo-beta-lactamase in complex with 3-oxo-2- phenylisoindoline-4-carboxylic acid (compound 30) (10.1039/C6SC04524C )
• 5LCH: vim-2 metallo-beta-lactamase in complex with (s)-1-allyl-2-(3- methoxyphenyl)-3-oxoisoindoline-4-carboxylic acid (compound 42) (10.1039/C6SC04524C )
• 5LE1: vim-2 metallo-beta-lactamase in complex with 2-(2-chloro-6- fluorobenzyl)-3-oxoisoindoline-4-carboxylic acid (compound 16) (10.1039/C6SC04524C )
• 5LM6: vim-2 metallo-beta-lactamase in complex with 2-(3-fluoro-4- hydroxyphenyl)-3-oxoisoindoline-4-carboxylic acid (compound 35) (10.1039/C6SC04524C )
• 5LSC: the structure of the metallo-beta-lactamase vim-2 in complex with a triazolylthioacetamide inhibitor (10.1107/S2053230X16016113 )
• 5MM9: vim-2_2b. metallo-beta-lactamase inhibitors by bioisosteric replacement: preparation, activity and binding (10.1016/J.EJMECH.2017.04.035 )
• 5MXQ: crystal structure of the acquired vim-2 metallo-beta-lactamase in complex with ant-90 inhibitor (10.1021/ACSINFECDIS.8B00246 )
• 5MXR: crystal structure of the acquired vim-2 metallo-beta-lactamase in complex with ant-330 inhibitor (10.1021/ACSINFECDIS.8B00246 )
• 5N4S: vim-2 metallo-beta-lactamase in complex with ((s)-3-mercapto-2- methylpropanoyl)-d-tryptophan (compound 3) (10.1039/C7CC02394D )
• 5N4T: vim-2 metallo-beta-lactamase in complex with ((s)-3-mercapto-2- methylpropanoyl)-l-tryptophan (compound 4) (10.1039/C7CC02394D )
• 5N55: mono-zinc vim-5 metallo-beta-lactamase in complex with (1-chloro-4- hydroxyisoquinoline-3-carbonyl)-l-tryptophan (compound 2) (10.1039/C7CC02394D )
• 5N58: di-zinc vim-5 metallo-beta-lactamase in complex with (1-chloro-4- hydroxyisoquinoline-3-carbonyl)-d-tryptophan (compound 1) (10.1039/C7CC02394D )
• 5N5G: crystal structure of di-zinc metallo-beta-lactamase vim-1 (10.1111/FEBS.14695 )
• 5N5H: crystal structure of metallo-beta-lactamase vim-1 in complex with ml302f inhibitor (10.1111/FEBS.14695 )
• 5N5I: crystal structure of vim-1 metallo-beta-lactamase in complex with hydrolysed meropenem (10.1111/FEBS.14695 )
• 5NAI: mono-zinc vim-5 metallo-beta-lactamase in complex with (1-chloro-4- hydroxyisoquinoline-3-carbonyl)-d-tryptophan (compound 1) (10.1039/C7CC02394D )
• 5NHZ: vim-2_10b. metallo-beta-lactamase inhibitors by bioisosteric replacement: preparation, activity and binding (10.1016/J.EJMECH.2017.04.035 )
• 5NI0: vim-2_10c. metallo-beta-lactamase inhibitors by bioisosteric replacement: preparation, activity and binding (10.1016/J.EJMECH.2017.04.035 )
• 5O7N: beta-lactamase vim-2 in complex with (2r)-1-(2-benzyl-3- mercaptopropanoyl)piperidine-2-carboxylic acid (10.1021/ACSINFECDIS.7B00129 )
• 5Y6D: vim-2 metallo-beta-lactamase in complex with (r)-2-(4-fluorophenyl)-2- ((s)-3-mercapto-2-methylpropanamido)acetic acid (compound 11) (10.1016/J.EJMECH.2018.01.032 )
• 5Y6E: vim-2 metallo-beta-lactamase in complex with (r)-2-(4-hydroxyphenyl)- 2-((s)-3-mercapto-2-methylpropanamido)acetic acid (compound 12) (10.1016/J.EJMECH.2018.01.032 )
• 5YD7: crystal structure of vim-2 metallo-beta-lactamase
• 6BM9: directed evolutionary changes in mbl super family - vim-2 round 10 (10.7554/ELIFE.40789 )
• 6DD0: crystal structure of vim-2 complexed with compound 8 (10.1021/ACS.JMEDCHEM.9B00728 )
• 6DD1: crystal structure of vim-2 complexed with compound 14 (10.1021/ACS.JMEDCHEM.9B00728 )
• 6EW3: crystal structure of the metallo-beta-lactamase vim-2 with ml302f (10.1016/J.BMC.2018.02.043 )
• 6HF5: crystal structure of the acquired vim-2 metallo-beta-lactamase in complex with ant-431 inhibitor (10.1021/ACSINFECDIS.8B00246 )
• 6J8R: metallo-beta-lactamase vim-2 in complex with dual mbl/sbl inhibitor ms01 (10.1021/ACS.JMEDCHEM.9B00735 )
• 6JN6: metallo-beta-lactamase vim-2 in complex with dual mbl/sbl inhibitor ms19 (10.1021/ACS.JMEDCHEM.9B00735 )
• 6KW1: the structure of the metallo-beta-lactamase vim-2 in complex with a triazolylthioacetamide 1b (10.3390/BIOM10010072 )
• 6KXO: crystal structure of vim-2 metallo-beta-lactamase in complex with inhibitor no9
• 6KZN: crystal structure of vim-2 metallo-beta-lactamase in complex with inhibitor x2
• 6O5T: crystal structure of vim-2 with compound 16 (10.1021/ACS.JMEDCHEM.9B00728 )
• 6OP6: structure of vim-20 in the reduced state (10.1128/MBIO.02412-19 )
• 6OP7: structure of oxidized vim-20 (10.1128/MBIO.02412-19 )
• 6RPN: structure of metallo beta lactamase vim-2 with cyclic boronate apc308. (10.1021/ACSINFECDIS.9B00330 )
• 6SP7: crystal structure of the vim-2 acquired metallo-beta-lactamase in complex with taniborbactam (vnrx-5133) (10.1021/ACS.JMEDCHEM.9B01518 )
• 6TGI: crystal structure of vim-2 in complex with triazole-based inhibitor op24 (10.1038/S41598-020-69431-Y )
• 6TM9: vim-2_1cc-. triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-beta-lactamases 10-feb-21 6tm9 1 title (10.1016/J.BMC.2020.115598 )
• 6TMA: vim-2_1dj- triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-beta-lactamases (10.1016/J.BMC.2020.115598 )
• 6TMB: vim-2_1di-triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-beta-lactamases (10.1016/J.BMC.2020.115598 )
• 6TMC: vim-2_1dh-triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-beta-lactamases 10-feb-21 6tmc 1 title 02-sep-20 6tmc 1 title (10.1016/J.BMC.2020.115598 )
• 6V1P: structure of vim-2 bound to qpx7728 at 1.20 a (10.1021/ACS.JMEDCHEM.9B01976 )
• 6Y6J: vim-2 in complex with biapenem imine and enamine hydrolysis products
• 6YRP: crystal structure of the vim-2 acquired metallo-beta-lactamase in complex with jmv-4690 (cpd 31) (10.1016/J.EJMECH.2020.112720 )
• 6ZGM: crystal structure of the vim-2 acquired metallo-beta-lactamase in complex with the thiazolecarboxylate inhibitor ant2681 (10.1021/ACSINFECDIS.0C00207 )
• 6ZYN: structure of vim-2 with 2-mercaptomethyl-thiazolidine l-anti-1b (10.1039/D0SC05172A )
• 6ZYO: structure of vim-2 with 2-mercaptomethyl-thiazolidine d-syn-1b (10.1039/D0SC05172A )
• 7A5Z: structure of vim-2 metallo-beta-lactamase with hydrolysed faropenem imine product (10.1016/J.EJMECH.2021.113257 )
• 7A60: crystal structure of vim-2 with hydrolyzed faropenem (ring-open form) (10.1016/J.EJMECH.2021.113257 )
• 7AYJ: metallo beta-lactamse vim-1 with a sulfamoyl inhibitor. (10.1021/ACSINFECDIS.1C00104 )
• 7CHV: metallo-beta-lactamase vim-2 in complex with 1-benzyl-1h-imidazole-2- carboxylic acid
• 7CJL: metallo-beta-lactamase vim-2 in complex with (s)-n-(3-(2h-tetrazol-5- yl)phenyl)-3-mercapto-2-methylpropanamide